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The RE-1 silencing transcription
factor or neuron-restrictive
silencer factor (REST/NRSF) was
first described in 1995 [1,2] and,
over the intervening decade, many
studies have gradually elucidated
the biological mechanisms and
physiological importance of this
zinc finger transcription factor.
This work has shown that
REST/NRSF not only maintains
transcriptional silencing of a range
of neuronal genes in differentiated
non-neuronal cells, but also has
key roles during early lineage
commitment in neurogenesis and
in mediating transcriptional
responses associated with neural
plasticity. In addition, REST/NRSF
dysfunction has been implicated
in diverse diseases ranging from
Down's syndrome to
cardiomyopathy and cancer,
emphasising its importance as a
master regulator of normal gene
expression programs.
REST/NRSF was initially
identified as a transcriptional
repressor of the stathmin SCG10
[2] and the type II sodium channel
[1], but was subsequently shown
to regulate many neuronal genes.
REST/NRSF recognises neuron-
restrictive silencing element
(NRSE) motifs within the control
regions of these genes through its
zinc finger domain and recruits
multiple co-factors via two
repression domains, one at the
amino terminus and one at the
carboxyl terminus. These co-
factors alter chromatin structure
and regulate transcription through
histone deacetylation [3],
chromatin remodelling [4] and
methylation [5] (Figure 1).
Simplistically, the lack of
REST/NRSF in mature neurons
decondenses chromatin, thereby
relieving neuronal gene
repression. However, two recent
papers [6,7] now show that loss of
REST/NRSF is key to two
processes that are superficially at
odds — the terminal
differentiation of post-mitotic
neurons and the progression to
cancer.
Transcription factors
co-ordinate complex gene
expression programs during
development, the corollary to
which is that their deregulation in
cancer often activates aberrant
foetal-like transcription patterns.
Whilst advances in understanding
REST/NRSF function have largely
emerged from the neurobiology
field, REST/NRSF also regulates a
cardiac foetal gene expression
program and reactivates this
program in cardiac dysfunction
[8]. REST/NRSF was first linked
with specific cancers five years
ago from studies in
medulloblastoma [9],
neuroblastoma [10] and small cell
lung cancer [11]. A role in
tumorigenesis now seems more
likely to be widely recognised,
division, at a local, cell specific
level is important. This represents
an economical mechanism for
harnessing a globally important
signalling pathway to control
tissue specific developmental
switches and is reminiscent—
conceptually, though not
mechanistically—of the reiterative
use of important signalling
pathways during animal
development. With 173 RLPs
similar to at least twenty
subfamilies of receptor-like
kinases predicted in the
Arabidopsis genome [12], it is
possible that regulation of many
receptor-like kinases by similar
mechanisms lies waiting to be
discovered. This study therefore
also establishes control of
ERECTA signalling during
stomatal development as an
excellent system with which to
investigate a potentially crucial
and largely plant-specific
mechanism for the regulation of
receptor-like kinase signalling.
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Transcriptional Regulation:
Cancer, Neurons and the REST
REST/NRSF was first identified as a transcriptional repressor of
neuronal genes in non-neuronal cells. Recent studies have now
revealed seemingly paradoxical roles for REST/NRSF in neurogenesis,
neural plasticity, tumour suppression and cancer progression.
given that it has emerged as one
of the first tumour suppressors to
be predicted from an unbiased
RNA interference (RNAi) library
screen in one of the two recent
studies [7].
In this work, RNAi-mediated
epithelial cell transformation was
screened using an in vitro breast
cancer precursor model, and
REST/NRSF was one of only five
candidate genes that survived
validation. Anchorage-
independent growth was
promoted by REST/NRSF
knockdown in this model, but
suppressed by REST/NRSF
overexpression in a colon cancer
cell line. Interestingly, the genomic
region around at least one
REST/NRSF allele was deleted in a
third of colon cancers supporting
a role for this transcriptional
repressor as a tumour suppressor
[7]. Both breast and colon cancer
can display some neuroendocrine
features and reduced transcription
of REST/NRSF is well documented
in small cell lung cancer [11,12],
where many neuroendocrine
genes that would normally be
restricted through NRSE motifs in
non-neuronal cells are aberrantly
expressed [13,14]. These findings
are corroborated by the loss of
REST/NRSF function
accompanying the acquisition of
the neuroendocrine phenotype in
LNCaP prostate cancer cells [15].
This trans-differentiation is
associated with androgen-
independent progression,
suggesting that REST/NRSF
dysfunction could contribute to
worsening of disease.
Differential splicing of
REST/NRSF also occurs in
neurons and some typically
neuroendocrine cancers [10,11].
In human cell lines derived from
neuroblastoma and small cell lung
cancer additional exons introduce
a frameshift and premature
termination. The resulting
transcripts encode the
sNRSF/hREST-N62 isoforms,
which have a truncated DNA-
binding domain and lack the
carboxy-terminal repression
domain. Interestingly, a mutation
identified in one colon cancer cell
line also leads to premature
translational termination, in this
case encoding the REST-FS
isoform, which lacks the carboxyl
terminus and is capable of
stimulating anchorage-
independent growth [7]. Thus,
these tumours can employ
independent strategies to
generate carboxy-terminal deleted
variants that eschew key
transcriptional silencing
mechanisms as an alternative
route to modulate REST/NRSF
function (Figure 2).
Loss of REST/NRSF gene
expression by genetic deletion
does not therefore appear to
provide a generic model that
applies to all cancers. In fact,
REST/NRSF is upregulated in
medulloblastoma relative to
differentiated neurons or neural
progenitors [9]. A recombinant
dominant negative version of
REST/NRSF that activates its
target genes was recently shown
in elegant in vivo models to block
the tumorigenicity of
medulloblastoma cells and inhibit
growth of established tumours
[16]. Taken together, these
studies therefore present several
conundrums. Firstly, how do we
functionally rationalise loss of
REST/NRSF expression in both
terminally differentiated post-
mitotic neurons and rapidly
proliferating cancer cells?
Secondly, how does
overexpression of a protein with
tumour suppressor properties
drive carcinogenesis? Fortunately,
the elucidation of a range of
changes in REST/NRSF and its
co-repressors during
neurogenesis provides useful
clues.
The REST/NRSF co-repressor
complex seems to be dynamic
and vary in composition
depending on the target gene, the
cell context, or specific stimuli
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Figure 1. The availability of REST/NRSF and dynamic co-factor complexes regulates
neuronal gene expression in development and plasticity.
(A) REST/NRSF assembles co-factors on target genes. The amino terminus of
REST/NRSF recruits Sin3–histone deacetylase (HDAC) to mediate active repression of
neuronal genes. The carboxyl terminus recruits a large complex via the specific co-
repressor CoREST, which can include Sin3–HDAC, SWI/SNF remodelling components
(not shown), the methyl-DNA-binding protein MeCP2, histone H3 K9 methyltransferases
and HP1 (not shown) to mediate epigenetic silencing in non-neuronal cells. The co-
repressor complex dependent on bound REST/NRSF represses transcription through
mechanism 1, whilst REST/NRSF-directed co-factor association with methylated DNA
in mechanism 2 is released in response to stimulation that induces transcription, for
example KCl-induced membrane depolarisation of cortical neurons [6]. (B) Titration of
REST/NRSF levels occurs as neurogenesis proceeds to release repression of individ-
ual subsets of neuronal genes, initially those with lower affinity RE1/NRSE motifs, then
class I genes that use only mechanism 1 for transcriptional repression. Class II genes
that also use repression mechanism 2 may only be maximally expressed by stimulus
induction (see above) [6].
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[5,17]. A recent paper by Mandel
and colleagues [6] now highlights
the importance of these variables
during transcriptional changes in
neurogenesis and neural
plasticity. They show that the
availability of REST/NRSF is
reduced in pluripotent stem cells,
neural progenitors and mature
cortical neurons, whilst the
assembled co-repressor
complexes differ between these
cells (Figure 1). Integration of
these changes allows titration of
REST/NRSF away from NRSE
motifs with different affinity and
the independent regulation of two
gene classes. The first class is
automatically expressed upon
loss of REST/NRSF at neuronal
maturation, whilst the second
class exhibits low expression. The
latter retains associated co-
repressors at methylated DNA,
even in the absence of
REST/NRSF, but stimulus-
inducible changes in binding of
these co-factors subsequently
permit transcriptional plasticity in
mature neurons [6] (Figure 1).
Ultimately, whether in normal or
cancerous cells, the activity of
REST/NRSF is affected by its
expression level, its regulation by
splicing and its affinity for target
genes. This range of regulatory
events is then balanced against
the particular co-factor complexes
that are recruited and other
potential modifiers of REST/NRSF
function [18,19]. Although
dysfunction of REST/NRSF is
evident in several cancers, this
appears to be achieved through
diverse routes (Figure 2).
Medulloblastomas are thought to
arise by retention or reinitiation of
REST/NRSF expression in
neuroectodermal stem cells
accompanying a failure to
differentiate [16]. Logically, in
contrast to the reduction of
REST/NRSF during normal neural
differentiation, this generates
proliferating cells where many
target genes characteristic of
post-mitotic neurons are silenced.
But how does this compare with
other cancers where REST/NRSF
is lost? In either the breast cancer
epithelium model [7] or
physiological precursor cells for
tumours, REST/NRSF would
normally be retained to silence
neuronal genes. However, when it
is lost in proliferating cells, some
neuronal genes will be expressed
out of their normal context. If this
loss is incomplete, cancer cells
may more closely resemble
poised neural progenitors than
mature neurons, remaining in the
cell cycle but titrating REST/NRSF
from selected NRSE motifs to
express some target genes. In
neuroendocrine tumours,
alternative REST/NRSF isoforms
may also exert different
transcriptional changes.
For the importance of
REST/NRSF in cancer to be fully
appreciated, the altered gene
expression programs that follow
its loss, gain or modified function
during tumorigenesis in various
tissues will need to be elucidated.
Several target genes are known to
be expressed in lung cancer, with
roles suggested for stimulatory
neuropeptides such as
vasopressin [13] and for the
glycine receptor [12]. In prostate
cancer, REST/NRSF controls
expression of the scaffold protein
IB1/JIP-1, which regulates JNK
activation and cell survival [15],
whilst impaired REST/NRSF
function in the breast cancer
model stimulated phosphorylation
of Akt, an essential effector of
phosphatidylinositol 3-kinase
signalling [7]. Thus the outputs
may prove as diverse as the
routes to achieving REST/NRSF
dysfunction. Bioinformatic and
biochemical approaches suggest
that around two thousand genes
harbour NRSE motifs that
differentially recruit REST/NRSF
[20]. Many have neuronal
functions, but how many will
prove important in the
establishment or progression of
cancer?
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Figure 2. Experimental models and possible routes for REST/NRSF dysfunction in
cancer.
(A,B) In cell line models experimental strategies that reduce REST/NRSF levels or inac-
tivate REST/NRSF are associated with transformation or progression of the cancer phe-
notype [7,15]. (C) However, active REST/NRSF is overexpressed in medulloblastoma
[16]. (D–F) In other cancers, genetic deletion or depletion of REST/NRSF may be
accompanied by mutation (D) or alternative splicing (E,F) generating REST-FS [7],
sNRSF [11] or hREST-N62 [10] isoforms, respectively, each of which lacks the carboxy-
terminal repression domain.
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Odour molecules are detected
when they bind to a cognate
seven transmembrane receptor
located on the dendrites of
olfactory receptor neurons
(ORNs). This activates a G-protein
signalling cascade, producing an
action potential that travels down
the axon to the brain. The
pioneering of work of Buck and
Axel [1] identified the first
members of what has turned out
to be a very large family of
olfactory receptor genes — over a
thousand in mice (reviewed in [2]).
In Drosophila the 50 or so
classes of olfactory receptor
neuron are dispersed into two
external sensory structures, the
third antennal segment and the
maxillary palp (Figure 1A). There
are about 1300 ORNs on each side
of the brain that send axons to the
antennal lobe, the fly’s equivalent
of the mammalian olfactory bulb.
Two principles have emerged
from work on vertebrate
olfaction — the central dogma of
olfactory molecular biology, as it
were: first, each neuron expresses
only one type of receptor. Second,
each glomerulus is the site of
convergence of only one type of
receptor neuron (Figure 2A). It
should be emphasised though that
the evidence for these assertions
remains indirect — no one has
actually done the heroic
experiment of attempting to probe
individual receptor neurons for all
the hundreds of receptors they
could possibly express.
Two new studies in this issue of
Current Biology [3,4] now provide
an almost complete molecular
map of the olfactory system of the
fruitfly. By generating a series of
transgenic flies in which discrete
ORN classes have been labelled,
Couto et al. [4] and Fishilevich and
Vosshall [3] have been able to
determine almost the entire set of
connections that relay olfactory
information from the fly’s antennae
to its brain. For the general
biologist, these data confirm the
organisational principles outlined
above for a whole sensory system;
for the specialist, they provide a
treasure trove of information that
will inform studies of development,
functional organisation and
evolution of the olfactory system.
Olfactory Cartography — One
Receptor, One Neuron
The completion of the Drosophila
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number of groups to identify a
family of olfactory receptor genes
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Insect Olfaction: A Map of Smell in
the Brain
Humans use three classes of photoreceptor to span the visible
spectrum, but smell relies on hundreds of distinct classes of olfactory
receptor neuron. Even the simple fruitfly has around 50 classes of
olfactory receptor neuron. Two new studies map the projections of the
great majority of these neurons into stereotyped positions in the fly
brain, giving us an almost complete atlas of olfactory information
transfer.
